ProPhase Labs, Inc. Disposal Group, Including Discontinued Operation, Assets, Noncurrent
ProPhase Labs, Inc. (PRPH) had Disposal Group, Including Discontinued Operation, Assets, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent · last filed 2026-06-01
- 2025-12-31: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2025-09-30: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2025-06-30: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2025-03-31: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-06-01 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-19 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-20 |
| 2024-12-31 | $5.44M 10-K · filed 2026-06-01 |
| 2023-12-31 | $2.57M 10-K · filed 2025-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |